Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis: Lessons Learned from a Feasibility Study in the UK
- 1 December 2013
- journal article
- Published by Elsevier BV in Value in Health
- Vol. 16 (8), 1156-1162
- https://doi.org/10.1016/j.jval.2013.10.003
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and TherapiesDermatology, 2012
- Exploration of health dimensions to be included in multi-attribute health-utility assessmentInternational Journal for Quality in Health Care, 2010
- Is the EQ–5D fit for purpose in mental health?The British Journal of Psychiatry, 2010
- Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based studyBritish Journal of Dermatology, 2007
- The Impact of Age-Related Macular Degeneration on Health Status Utility ValuesInvestigative Ophthalmology & Visual Science, 2005
- Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patientsIntensive Care Medicine, 2004
- Prevalence of symptoms experienced by patients with different clinical types of psoriasisBritish Journal of Dermatology, 2004
- Measuring Population HealthMedical Care, 2003
- The Effect of Adding a Cognitive Dimension to the EuroQol Multiattribute Health-Status Classification SystemJournal of Clinical Epidemiology, 1999
- POPULATION-BASED EPIDEMIOLOGIC STUDY OF PSORIASIS WITH EMPHASIS ON QUALITY OF LIFE ASSESSMENTDermatologic Clinics, 1996